Advertisement

Index by author

February 01, 1996; Volume 276,Issue 2

  1. Abboa-offei, B E

    1. Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors.
      A A Seymour, M M Asaad, B E Abboa-Offei, P L Smith, W L Rogers and C R Dorso
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 708-713;

  2. Abe, Y

    1. Calcium sensitization in perfused beating guinea pig heart by a positive inotropic agent MCI-154.
      Y Abe, R Ishisu, K Onishi, K Sekioka, A Narimatsu and T Nakano
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 433-439;

  3. Abi-younes, S

    1. Estradiol increases cyclic adenosine monophosphate in rat pulmonary vascular smooth muscle cells by a nongenomic mechanism.
      M Y Farhat, S Abi-Younes, B Dingaan, R Vargas and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 652-657;

  4. Adler, A L

    1. Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist.
      T J Opgenorth, A L Adler, S V Calzadilla, W J Chiou, B D Dayton, D B Dixon, L J Gehrke, L Hernandez, S R Magnuson, K C Marsh, E I Novosad, T W Von Geldern, J L Wessale, M Winn and J R Wu-Wong
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 473-481;

  5. Agnati, L F

    1. Effects of single and short-term administration of clonidine on hypothalamic-pituitary somatotropic function of the adult male rat: an in situ hybridization study.
      V De Gennaro Colonna, M Zoli, B P Settembrini, S Ciceri, A De Marco, S G Cella, L F Agnati and E E Muller
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 795-800;

  6. Ali, H

    1. Sustained activation of phospholipase D via adenosine A3 receptors is associated with enhancement of antigen- and Ca(2+)-ionophore-induced secretion in a rat mast cell line.
      H Ali, O H Choi, P F Fraundorfer, K Yamada, H M Gonzaga and M A Beaven
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 837-845;

  7. Alkana, R L

    1. Low level hyperbaric antagonism of diazepam's locomotor depressant and anticonvulsant properties in mice.
      D L Davies, M Bejanian, E S Parker, J Mørland, M B Bolger, R D Brinton and R L Alkana
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 667-675;

  8. Asaad, M M

    1. Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors.
      A A Seymour, M M Asaad, B E Abboa-Offei, P L Smith, W L Rogers and C R Dorso
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 708-713;

  9. Baez, M

    1. Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: evidence for species differences.
      D B Wainscott, V L Lucaites, J D Kursar, M Baez and D L Nelson
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 720-727;

  10. Baraldi, P G

    1. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
      C Zocchi, E Ongini, A Conti, A Monopoli, A Negretti, P G Baraldi and S Dionisotti
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 398-404;
« Previous (Pages : 1 2 3 4 5 6 ... 31) Next »
Back to top

In this issue

Advertisement